Skip to content
lifestyle.utv.ie
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
KYE Pharmaceuticals Inc.
Kye Pharmaceuticals places No. 105 on The Globe and Mail’s eighth annual ranking of Canada’s Top Growing Companies.
September 25, 2026
SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS).
August 11, 2026
Kye Pharmaceuticals Announces the Availability of Dyanavel® XR Tablets Across Canada for the Treatment of ADHD
June 8, 2026